You are here
Home 🌿 Cannabis Technology News 🌿 CBD forecasts likely to be slashed on FDA warning: Analyst 🌿News Categories
CBD forecasts likely to be slashed on FDA warning: Analyst

CBD wholesalers should “have big concerns” about the U.S. Food and Drug Administration’s growing unease about the safety of the cannabis compound, according to one chief executive officer.
The FDA said Monday that it “cannot conclude that CBD is generally recognized as safe among qualified experts for its use in human or animal food.”
It added that “some of the available data raise serious concerns about potential harm from CBD,” including liver injury, drowsiness, diarrhea and changes in mood, and raised questions about its impact on children and pregnant or breastfeeding women.
This could cause big retailers to shy away from products containing cannabidiol, a non-intoxicating compound found in the cannabis plant, said Peter Horvath, CEO of Green Growth Brands Inc.
“It could be that this FDA thing causes the chains to either cut back or discontinue their CBD businesses,” Horvath said in a phone interview Tuesday. “I think if you’re in a strictly wholesale strategy and if you sell ingestibles, you’d have to have big concerns.”
Green Growth Brands primarily sells CBD topicals like lotions and bath oils at mall kiosks. It also has a small ingestibles business.
Consumer CBD stocks fell on the news, with CV Sciences Inc. down as much as 13 per cent. Charlotte’s Web Holdings Inc. lost 6.6 per cent and CbdMD Inc. slid 11 per cent.
The FDA’s statement “used an inappropriately alarmist tone,” Duffy MacKay, CV Sciences’ senior vice president of scientific and regulatory affairs, said in an emailed statement. “There are more direct ways for the FDA to address bad actors while still working with responsible companies to establish the appropriate scope of hemp-derived ingredients for supplements based on sound research.”
Bullish forecasts on CBD’s sales potential are likely to be slashed in the wake of the FDA’s “very cautious tone,” according to Jefferies analyst Owen Bennett, whose own model calls for retail sales of just US$3.5 billion in 2022.
The agency hasn’t made a final decision about how to regulate cannabidiol, which is a non-intoxicating compound found in the cannabis plant, but Monday’s statement indicates its approach is likely to be stringent, Bennett said.
“The safety risks as well as the spike in consumer interest will likely see heavy regulation (especially against the backdrop of the recent vapor deaths, an area where the FDA has arguably dropped the ball on regulation), with companies having to support product launches with detailed reports likely including clinical studies,” he said.
420 Intel is Your Source for Marijuana News
420 Intel is the leading source for cannabis news from around the world. Get the latest updates on cannabis legalization, politics and technology, as well as developments in medical and recreational marijuana news. Our commitment is to bring you the most important cannabis news stories every day of the week.
At 420 Intel we understand that effective marijuana industry news coverage is a constant endeavor. Every day stories develop regarding cannabis legalization, technological developments, and the medicinal benefits of marijuana use. Each new development carries the potential to impact the marijuana industry regionally, nationally, and internationally. 420 Intel is the marijuana industry news outlet that will keep you up to date on these developments and how they impact the world around you.
With the marijuana industry constantly evolving, you need a cannabis news outlet to keep you abreast of the pertinent information. At 420 Intel, we cover marijuana legalization news throughout the world, offer reliable information for cannabis business owners, detail technological advances that impact the marijuana industry, cover marijuana rallies from across the globe, and everything in between.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.